Tag Archives: Gallium 68

3rd Theranostics World Congress Offers Free Patient Program on March 14

Johns Hopkins University in Baltimore, Maryland will be the site of the 3rd Theranostics World Congress on Ga-68 & PRRT from March 12-14, 2015. Co-sponsored by the Society of Nuclear Medicine and Molecular Imaging and Johns Hopkins Medicine, the Congress … Continue reading

Posted in carcinoid cancer, neuroendocrine tumors, nuclear imaging | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

First Northeastern Facility Offers Gallium-68 DOTATOC PET/CT Imaging for Carcinoid and Neuroendocrine Cancer Patients

When Brian Hakimian had the 68Gallium DOTATOC PET/CT scan at the Icahn School of Medicine, Mount Sinai in New York City on January 14, 2015, he became the first carcinoid patient to undergo this novel imaging test at a northeastern facility. … Continue reading

Posted in carcinoid, neuroendocrine cancer | Tagged , , , , , , , , , , , , , , , , , , , , , | 3 Comments

10 Highlights of the Year 2014 for the Carcinoid and Neuroendocrine Tumor Community

As the Carcinoid Cancer Foundation looks back on the year 2014, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past year. … Continue reading

Posted in carcinoid, neuroendocrine tumors | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 4 Comments

Gallium-68 Scan Coming to NOLANETS for Carcinoid and Neuroendocrine Tumor Patients

Dr. Eugene A. Woltering has announced that the Gallium-68 DOTATATE PET/CT scan is going to be available beginning in the summer of 2014 through The New Orleans Louisiana Neuroendocrine Tumor Specialists (NOLANETS) Neuroendocrine Tumor Program at Ochsner Medical Center in … Continue reading

Posted in carcinoid, clinical trials, neuroendocrine tumors | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | 8 Comments

10 Highlights of the Year 2013 for the Carcinoid and Neuroendocrine Tumor Community

As the Carcinoid Cancer Foundation looks back on the year 2013, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past year.  … Continue reading

Posted in carcinoid, neuroendocrine tumors | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

Excel Diagnostics and Nuclear Oncology Center Selected For New Investigational PRRT Treatment and Gallium Scan for Carcinoid and Neuroendocrine Tumor Patients

For carcinoid, pancreatic neuroendocrine tumor, and other NET cancer patients seeking the most advanced nuclear medicine opportunities in  the United States, Excel Diagnostics and Nuclear Oncology Center  in Houston, Texas, in collaboration with the RITA Foundation and RadioMedix, has now … Continue reading

Posted in carcinoid, neuroendocrine tumors, nuclear imaging | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

2nd World Congress on Ga-68, Molecular Imaging & Targeted Radionuclide Therapy

Chandigarh, India will be the site of the 2nd World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals), Molecular Imaging (PET/CT), Targeted Radionuclide Therapy and Dosimetry:  On the Way to Personalized Medicine from February 28 through March 2, 2013. The meeting … Continue reading

Posted in carcinoid, neuroendocrine tumors, nuclear imaging | Tagged , , , , , , , , , , , , , , , , , , , , | 1 Comment